It is a pharma limited liability partnership based in Ahmedabad, Gujarat, India, established in 2020.
2020 | Ahmedabad, Gujarat, India | ActiveCanbio Pharmaceuticals Llp, a active limited liability partnership, was established on 12 June 2020 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAS-5978. Registered under ROC Roc Ahmedabad. It has total obligation of contribution of ₹0.10 M.
Its leadership includes Bharatkumar Vitthalbhai Patel (Designated Partner), Harsukhbhai Jasmatbhai Vekaria (Designated Partner), Kishorkumar Vrajlal Rakholiya (Designated Partner). Past directors included Bhupendrabhai Valjibhai Patel, Rabindra Kumar Mohanty, Hiren Bhupendrabhai Patel. It holds ₹7.15 Cr open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2025. It is based at Plot No 247 248 1 Phase 1 , G.I.D.C ,Naroda, Ahmedabad, Gujarat, 382330.
AAS-5978
12 June 2020
₹0.10 M
Roc Ahmedabad
Active
Explore comprehensive insights into Canbio Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bharatkumar Vitthalbhai Patel | Designated Partner | 03 Oct 2024 | Current |
| Harsukhbhai Jasmatbhai Vekaria | Designated Partner | 12 Jun 2020 | Current |
| Kishorkumar Vrajlal Rakholiya | Designated Partner | 03 Oct 2024 | Current |
| Dwij Kishorbhai Rakholiya | Designated Partner | 01 Aug 2025 | Current |
| Rahul Rajaram Kondekar | Designated Partner | 01 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Designated Partner | 03 Oct 2024 | Past |
| Pramod Abcsdd | Partner | 01 Sep 2020 | Past |
| Pramod Abcsdd | Partner | 01 Sep 2020 | Past |
| Pramod Abcsdd | Partner | 01 Sep 2020 | Past |
| Pramod Abcsdd | Designated Partner | 03 Oct 2024 | Past |
| Pramod Abcsdd | Designated Partner | 03 Oct 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Canbio Pharmaceuticals Llp, for the financial year ended 2024, experienced significant growth in revenue, with a 121.05% increase. The company also saw a substantial improvement in profitability, with a 136.08% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
Unlock access to Canbio Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹71,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Dec 2024 | Icici Bank Limited | ₹7.50 M | Open |
| 24 Dec 2024 | Icici Bank Limited | ₹3.40 Cr | Open |
| 15 Feb 2021 | Bank Of Baroda | ₹3.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Canbio Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Canbio Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Canbio Pharmaceuticals Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Dwij Kishorbhai Rakholiya was appointed as a Designated Partner was appointed as a Designated Partner on 01 Aug 2025 & has been associated with this company since 4 months 1 day . was documented.
Rahul Rajaram Kondekar was appointed as a Designated Partner was appointed as a Designated Partner on 01 Aug 2025 & has been associated with this company since 4 months 1 day . was recorded as a recent event.
Progress on A charge with Icici Bank Limited of Rs. 34.00 M registered on 24 Dec 2024 with Charge ID 101067905 was modified on 23 Jul 2025. was documented.
Canbio Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was recorded as a recent event.
Canbio Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
Progress on A charge with Icici Bank Limited amounted to Rs. 7.50 M with Charge ID 101067909 was registered on 24 Dec 2024. was documented.
The LLPIN of Canbio Pharmaceuticals Llp is AAS-5978.
Canbio Pharmaceuticals Llp is headquartered at Plot No 247 248 1 Phase 1 , G.I.D.C ,Naroda, Ahmedabad, Gujarat, 382330.
Canbio Pharmaceuticals Llp was incorporated on 12 June 2020.
The current directors of Canbio Pharmaceuticals Llp are
The primary industry of Canbio Pharmaceuticals Llp is Pharma.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX